Suppr超能文献

印度学术急诊专家参与的印美联合工作组及OPUS12基金会关于创建一个协调、多学科、以患者为中心的全球即时护理生物标志物发现网络的共识声明。

Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network.

作者信息

Stawicki Stanislaw P, Stoltzfus Jill C, Aggarwal Praveen, Bhoi Sanjeev, Bhatt Shashi, Kalra O P, Bhalla Ashish, Hoey Brian A, Galwankar Sagar C, Paladino Lorenzo, Papadimos Thomas J

机构信息

Department of Research and Innovation, Research Institute, Bethlehem, Pennsylvania ; Department of Research and Innovation, OPUS 12 Foundation Global, Columbus, USA.

Department of Research and Innovation, Research Institute, Bethlehem, Pennsylvania ; Department of Research and Innovation, Research Institute, Bethlehem, Pennsylvania.

出版信息

Int J Crit Illn Inj Sci. 2014 Jul;4(3):200-8. doi: 10.4103/2229-5151.141398.

Abstract

Biomarker science brings great promise to clinical medicine. This is especially true in the era of technology miniaturization, rapid dissemination of knowledge, and point-of-care (POC) implementation of novel diagnostics. Despite this tremendous progress, the journey from a candidate biomarker to a scientifically validated biomarker continues to be an arduous one. In addition to substantial financial resources, biomarker research requires considerable expertise and a multidisciplinary approach. Investigational designs must also be taken into account, with the randomized controlled trial remaining the "gold standard". The authors present a condensed overview of biomarker science and associated investigational methods, followed by specific examples from clinical areas where biomarker development and/or implementation resulted in tangible enhancements in patient care. This manuscript also serves as a call to arms for the establishment of a truly global, well-coordinated infrastructure dedicated to biomarker research and development, with focus on delivery of the latest discoveries directly to the patient via point-of-care technology.

摘要

生物标志物科学给临床医学带来了巨大希望。在技术小型化、知识快速传播以及新型诊断技术的即时检验(POC)应用的时代,情况尤其如此。尽管取得了巨大进展,但从候选生物标志物到经过科学验证的生物标志物的历程仍然十分艰巨。除了大量资金资源外,生物标志物研究还需要相当多的专业知识和多学科方法。还必须考虑研究设计,随机对照试验仍然是“金标准”。作者简要概述了生物标志物科学及相关研究方法,随后列举了临床领域的具体实例,在这些领域中生物标志物的开发和/或应用切实改善了患者护理。本手稿还呼吁建立一个真正全球化、协调良好的基础设施,致力于生物标志物的研发,重点是通过即时检验技术将最新发现直接提供给患者。

相似文献

3
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
6
Critical Care Network in the State of Qatar.卡塔尔国重症监护网络。
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.

引用本文的文献

本文引用的文献

9
Molecular imaging biomarkers for oncology clinical trials.肿瘤临床研究的分子影像生物标志物。
J Nucl Med. 2014 Apr;55(4):525-8. doi: 10.2967/jnumed.113.126128. Epub 2014 Mar 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验